Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 293 of 5804
-
Half-Dose malaria vaccine could double protection for millions
⭐️ VACCINE ⭐️ Not yet recruitingThis is a single blind randomised controlled trial (Phase 3 trial). This study aims to assess whether a half-dose of the R21/Matrix-M malaria vaccine is as effective as the full dose in children and adults. The results will help optimize vaccine usage and improve malaria preventi…
Phase: PHASE4 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:01 UTC
-
Engineered immune cells from cord blood take on tough lymphoma
Disease control Recruiting nowThis study aims to evaluate the safety and efficacy of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 (TRBC1/2 CAR-NK cells) in patients with refractory or relapsed peripheral T-cell lymphoma (PTCL).
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Immune booster: donor NK cells aim to cut cancer recurrence
Disease control Not yet recruitingThis clinical trial aims to determine whether Natural Killer (NK) cell therapy administered in combination with concurrent chemoradiotherapy (CRT) can reduce recurrence in patients with advanced nasopharyngeal cancer (NPC), and to identify the highest safe and tolerable dose of a…
Phase: PHASE1, PHASE2 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a blood pressure cuff help fight septic shock?
Disease control Not yet recruitingSeptic shock is a leading cause of death worldwide despite intensive research efforts. Only a few interventions have been proven to be effective in improving patient-centered outcomes. Recent clinical trials have reported the safety and efficacy of remote ischemic postconditionin…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New vaccine aims to shield african infants from two deadly infections
⭐️ VACCINE ⭐️ Recruiting nowThe purpose of this study is to evaluate the safety, reactogenicity, and immune response induced by the GlaxoSmithKline Biologicals SA (GSK) Vaccines Institute for Global Health (GVGH) invasive nontyphoidal Salmonella-typhoid conjugate (iNTS-TCV) vaccine in infants with the first…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:10 UTC
-
New hybrid heart surgery aims to spare patients from open chest incision
Disease control Not yet recruitingThe MICRA-HYBRID trial is a prospective, multicenter, randomized controlled study comparing multivessel hybrid coronary revascularization (HCR) as minimally invasive arterial bypass grafting to left-sided coronary targets (LAD and LCx) plus PCI of the RCA versus conventional off-…
Phase: NA • Sponsor: Catharina Ziekenhuis Eindhoven • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Promising new combo aims to extend life in rare, Tough-to-Treat cancer
Disease control Not yet recruitingBackground Neuroendocrine carcinomas (NECs) of gastro-entero-pancreatic (GEP) or unknown (UK) origin are rare and highly aggressive diseases. The recommended first-line (L1) treatment is platinum-etoposide combination therapy, which has a progression-free survival (PFS) of only 4…
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New pill could ease lupus skin rashes in major trial
Disease control Recruiting nowThe purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous manifestations of lupus erythematosus with or without systemic disease. Study details include: Study Duration: Up to 35 …
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug could get heart surgery patients home days earlier
Disease control Not yet recruitingEA-230 is a new therapy that may help people recover faster and have fewer problems after bypass surgery. In an earlier clinical trial, participants who received EA-230 during Coronary Artery Bypass surgery stayed in the Intensive Care Unit (ICU) and the hospital for a shorter ti…
Phase: PHASE3 • Sponsor: EBI Anti Sepsis BV • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New study tests if diet and exercise can replace blood pressure pills
Disease control Not yet recruitingThe REMIDEP-HTA trial is a multicenter randomized controlled study designed to evaluate whether a structured approach combining an intensive lifestyle intervention with a systematic deprescribing algorithm can achieve clinical remission of essential hypertension. \<br\>\<br\> T…
Phase: NA • Sponsor: Evelyn Vanina Re • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Spinal injury breakthrough: brain zaps may restore grip
Symptom relief Recruiting nowThe goal of this study is to restore the activities of late descending signals with a noninvasive stimulation approach in combination with hand motor training to improve hand function in persons with cervical SCI. The main question it aims to answer is if the inputs to late desce…
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Magic mushroom compound may ease despair in advanced cancer patients
Symptom relief Recruiting nowDemoralization syndrome is frequently present in palliative care and oncology patients. In particular, up to a third of patients diagnosed with cancer will experience demoralization due to their illness. The relevance of demoralization syndrome in oncology is tied to this syndrom…
Phase: PHASE1 • Sponsor: Gustavo Vazquez • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Could a simple injection stop pancreatic leaks after surgery?
Prevention Not yet recruitingThis study is a randomized, double-blind, placebo-controlled, multicenter phase III clinical trial designed to evaluate the efficacy and safety of octreotide microspheres in preventing pancreatic fistula after distal pancreatectomy.
Phase: PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
New hope for stroke survivors: can a tiny tube in the brain prevent another attack?
Disease control Not yet recruitingA multicenter, randomized, open-label, endpoint-blinded trial to compare the effects of endovascular recanalization plus aggressive medical management with aggressive medical management alone on stroke recurrence and mortality in patients with symptomatic non-acute intracranial a…
Phase: NA • Sponsor: Feng Gao • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a tongue swab replace sputum tests for TB?
Diagnosis Not yet recruitingTuberculosis (TB) remains the leading cause of death from a single infectious agent globally, with millions of people still undiagnosed or diagnosed late. Conventional case-finding strategies rely heavily on symptom screening using the WHO Four-Symptom Screen ((W4SS; comprising a…
Phase: NA • Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
New drug duo aims to fight rare melanoma before surgery
Disease control Not yet recruitingThis study aims to investigate the efficacy and safety of SHR-1701 in combination with famitinib in the perioperative treatment of mucosal melanoma
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New lupus drug trial aims to tame the immune system
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of SCTC21C in participants with systemic lupus erythematosus
Phase: PHASE1, PHASE2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Clot-Busting heart procedure put to the test in massive new trial
Disease control Not yet recruitingThe goal of this clinical trial is to learn if adding standardized manual thrombus aspiration to primary percutaneous coronary intervention (PPCI) works better to improve heart health outcomes and protect long-term heart function in adults with acute ST-segment elevation myocardi…
Phase: NA • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New combo shows promise for Tough-to-Treat leukemia
Disease control ENROLLING_BY_INVITATIONThis study aims to evaluate the safety and efficacy of homoharringtonine combined with venetoclax and azacitidine regimen (HVA) in newly diagnosed MPAL patients, providing a basis for the use of the HVA regimen in the treatment of MPAL.
Phase: PHASE2 • Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug cocktail aims to free aplastic anemia patients from transfusions
Disease control Not yet recruitingThis study aimed to explore the efficacy and safety of cyclosporine (CsA) +eltrombopag (EPAG)/hetrombopag (HPAG)+romiplostim N01 in the treatment of newly-diagnosed transfusion-dependent aplastic anemia (TD-NSAA) and severe aplastic anemia (SAA)
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC